Symbols / HUM Stock $281.66 +2.70% Humana Inc.

Healthcare • Healthcare Plans • United States • NYQ
HUM (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Healthcare Plans
CEO Mr. James A. Rechtin M.B.A.
Exch · Country NYQ · United States
Market Cap 33.82B
Enterprise Value 25.40B
Income 1.13B
Sales 137.20B
FCF (ttm) 1.43B
Book/sh 146.42
Cash/sh 182.95
Employees 67,060
Insider 10d —
IPO Dec 31, 1981
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 37.78%
P/E 30.03
Forward P/E 18.45
PEG 1.56
P/S 0.25
P/B 1.92
P/C —
EV/EBITDA 7.55
EV/Sales 0.18
Quick Ratio 1.26
Current Ratio 1.77
Debt/Eq 77.07
LT Debt/Eq —
EPS (ttm) 9.38
EPS next Y 15.26
EPS Growth -4.60%
Revenue Growth 23.50%
EPS Gr Q/Q -4.70%
Rev Gr Q/Q —
Earnings (next) 2026-07-29
Earnings (prior) 2026-04-29
ROA 3.64%
ROE 6.28%
ROIC —
Gross Margin 14.01%
Oper. Margin 4.67%
Profit Margin 0.82%
Shs Outstand 120.06M
Shs Float 119.75M
Insider Own 0.21%
Instit Own 103.47%
Short Float 5.13%
Short Ratio 3.06
Short Interest 5.42M
52W High 315.35
vs 52W High -10.68%
52W Low 163.11
vs 52W Low 72.68%
Beta 0.68
Impl. Vol. 57.40%
Rel Volume 0.17
Avg Volume 1.79M
Volume 308.83K
Target (mean) $243.71
Tgt Median $252.50
Tgt Low $146.00
Tgt High $333.00
# Analysts 24
Recom Hold
Prev Close $274.26
Price $281.66
Change 2.70%
About

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$243.71
Mean price target
2. Current target
$281.37
Latest analyst target
3. DCF / Fair value
$214.60
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$281.37
Low
$146.00
High
$333.00
Mean
$243.71

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-01 main TD Cowen Hold → Hold $211
2026-05-01 main JP Morgan Neutral → Neutral $214
2026-04-30 main UBS Neutral → Neutral $262
2026-04-30 main RBC Capital Sector Perform → Sector Perform $246
2026-04-30 main Guggenheim Buy → Buy $269
2026-04-30 main Barclays Equal-Weight → Equal-Weight $180
2026-04-30 main Evercore ISI Group In-Line → In-Line $250
2026-04-30 main Truist Securities Hold → Hold $270
2026-04-13 main Truist Securities Hold → Hold $220
2026-04-08 main Evercore ISI Group In-Line → In-Line $195
2026-04-07 main Wells Fargo Equal-Weight → Equal-Weight $227
2026-02-25 main Barclays Equal-Weight → Equal-Weight $176
2026-02-18 main Wells Fargo Equal-Weight → Equal-Weight $206
2026-02-17 main Goldman Sachs Sell → Sell $158
2026-02-17 main Truist Securities Hold → Hold $200
2026-02-13 main TD Cowen Hold → Hold $173
2026-02-12 main Jefferies Buy → Buy $235
2026-02-12 main UBS Neutral → Neutral $195
2026-02-12 down RBC Capital Outperform → Sector Perform $189
2026-02-12 main Guggenheim Buy → Buy $252
News
RSS: Latest HUM news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-01 O'HARA MICHELLE A. Officer — 10,485 $0.00 $0
2026-05-01 SHETTY SANJAY K Officer — 9,945 $0.00 $0
2026-05-01 RECHTIN JAMES A. Chief Executive Officer — 35,633 $0.00 $0
2026-05-01 DINTENFASS DAVID Officer — 11,273 $0.00 $0
2026-05-01 MEHTA JAPAN Chief Technology Officer — 9,448 $0.00 $0
2026-05-01 MELLET CELESTE Chief Financial Officer — 15,387 $0.00 $0
2026-05-01 MARTIN AARON Officer — 8,206 $0.00 $0
2026-05-01 FIELD ROBERT STUART Director — 852 $0.00 $0
2026-05-01 VENTURA JOSEPH CHRISTOPHER Officer — 10,318 $0.00 $0
2026-04-01 SHETTY SANJAY K Officer — 887 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
129,664.00
+10.11%
117,761.00
+10.70%
106,374.00
+14.54%
92,870.00
Operating Revenue
129,664.00
+10.11%
117,761.00
+10.70%
106,374.00
+14.54%
92,870.00
Other Operating Expenses
15,901.00
+14.59%
13,877.00
+4.14%
13,325.00
+4.60%
12,739.00
Total Expenses
128,109.00
+10.40%
116,040.00
+12.67%
102,991.00
+15.33%
89,302.00
Reconciled Depreciation
824.00
-14.88%
968.00
+5.56%
917.00
+8.52%
845.00
EBIT
2,186.00
-8.19%
2,381.00
-38.57%
3,876.00
-2.34%
3,969.00
Total Unusual Items
-67.00
0.00
0.00
-100.00%
237.00
Total Unusual Items Excluding Goodwill
-67.00
0.00
0.00
-100.00%
237.00
Special Income Charges
-67.00
0.00
0.00
-100.00%
237.00
Other Special Charges
67.00
—
—
-237.00
Net Income
1,188.00
-1.57%
1,207.00
-51.51%
2,489.00
-11.30%
2,806.00
Pretax Income
1,555.00
-9.65%
1,721.00
-49.13%
3,383.00
-5.18%
3,568.00
Net Non Operating Interest Income Expense
-631.00
+4.39%
-660.00
-33.87%
-493.00
-22.94%
-401.00
Interest Expense Non Operating
631.00
-4.39%
660.00
+33.87%
493.00
+22.94%
401.00
Net Interest Income
-631.00
+4.39%
-660.00
-33.87%
-493.00
-22.94%
-401.00
Interest Expense
631.00
-4.39%
660.00
+33.87%
493.00
+22.94%
401.00
Tax Provision
250.00
-39.47%
413.00
-50.60%
836.00
+9.71%
762.00
Tax Rate For Calcs
0.00
-31.76%
0.00
+1.19%
0.00
+18.00%
0.00
Tax Effect Of Unusual Items
-11.66
0.00
0.00
-100.00%
50.61
Net Income Including Noncontrolling Interests
1,203.00
-0.91%
1,214.00
-51.13%
2,484.00
-11.35%
2,802.00
Net Income From Continuing Operation Net Minority Interest
1,188.00
-1.57%
1,207.00
-51.51%
2,489.00
-11.30%
2,806.00
Net Income From Continuing And Discontinued Operation
1,188.00
-1.57%
1,207.00
-51.51%
2,489.00
-11.30%
2,806.00
Net Income Continuous Operations
1,203.00
-0.91%
1,214.00
-51.13%
2,484.00
-11.35%
2,802.00
Minority Interests
-15.00
-114.29%
-7.00
-240.00%
5.00
+25.00%
4.00
Normalized Income
1,243.34
+3.01%
1,207.00
-51.51%
2,489.00
-4.99%
2,619.61
Net Income Common Stockholders
1,188.00
-1.57%
1,207.00
-51.51%
2,489.00
-11.30%
2,806.00
Diluted EPS
9.84
-1.40%
9.98
-50.10%
20.00
-9.42%
22.08
Basic EPS
9.87
-1.40%
10.01
-50.17%
20.09
-9.50%
22.20
Basic Average Shares
120.45
-0.10%
120.57
-2.66%
123.87
-2.02%
126.42
Diluted Average Shares
120.83
-0.04%
120.87
-2.87%
124.44
-2.09%
127.09
Diluted NI Availto Com Stockholders
1,188.00
-1.57%
1,207.00
-51.51%
2,489.00
-11.30%
2,806.00
Depreciation And Amortization In Income Statement
698.00
-16.81%
839.00
+7.70%
779.00
+9.87%
709.00
Earnings From Equity Interest Net Of Tax
-102.00
-8.51%
-94.00
-49.21%
-63.00
-1475.00%
-4.00
Loss Adjustment Expense
110,812.00
+10.08%
100,664.00
+13.88%
88,394.00
+16.78%
75,690.00
Net Policyholder Benefits And Claims
110,812.00
+10.08%
100,664.00
+13.88%
88,394.00
+16.78%
75,690.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
48,909.00
+5.23%
46,479.00
-1.25%
47,065.00
+9.31%
43,055.00
Cash Cash Equivalents And Short Term Investments
19,903.00
-2.60%
20,435.00
-4.15%
21,320.00
+12.55%
18,942.00
Cash And Cash Equivalents
4,200.00
+89.10%
2,221.00
-52.68%
4,694.00
-7.25%
5,061.00
Other Short Term Investments
15,703.00
-13.79%
18,214.00
+9.55%
16,626.00
+19.78%
13,881.00
Receivables
3,270.00
+20.93%
2,704.00
+32.87%
2,035.00
+21.57%
1,674.00
Accounts Receivable
3,270.00
+20.93%
2,704.00
+32.87%
2,035.00
+21.57%
1,674.00
Net PPE
2,231.00
-11.89%
2,532.00
-16.44%
3,030.00
-5.93%
3,221.00
Goodwill And Other Intangible Assets
10,814.00
-2.34%
11,073.00
-1.51%
11,243.00
+3.08%
10,907.00
Goodwill
9,686.00
+0.57%
9,631.00
+0.85%
9,550.00
+4.46%
9,142.00
Other Intangible Assets
1,128.00
-21.78%
1,442.00
-14.83%
1,693.00
-4.08%
1,765.00
Investments And Advances
16,834.00
-12.92%
19,332.00
+8.92%
17,748.00
+18.24%
15,010.00
Long Term Equity Investment
638.00
-8.46%
697.00
-5.81%
740.00
-1.20%
749.00
Total Liabilities Net Minority Interest
31,172.00
+3.79%
30,034.00
-2.32%
30,747.00
+11.06%
27,685.00
Payables And Accrued Expenses
15,990.00
-0.70%
16,102.00
-6.18%
17,163.00
+15.97%
14,800.00
Payables
15,990.00
-0.70%
16,102.00
-6.18%
17,163.00
+15.97%
14,800.00
Accounts Payable
15,684.00
-0.10%
15,699.00
-6.61%
16,810.00
+15.92%
14,502.00
Other Payable
306.00
-24.07%
403.00
+14.16%
353.00
+18.46%
298.00
Current Debt And Capital Lease Obligation
0.00
-100.00%
577.00
-60.01%
1,443.00
-54.78%
3,191.00
Current Debt
0.00
-100.00%
577.00
-60.01%
1,443.00
-54.78%
3,191.00
Other Current Borrowings
—
—
0.00
-100.00%
500.00
Long Term Debt And Capital Lease Obligation
12,369.00
+10.99%
11,144.00
+9.12%
10,213.00
+28.71%
7,935.00
Long Term Debt
12,369.00
+10.99%
11,144.00
+9.12%
10,213.00
+28.71%
7,935.00
Non Current Deferred Liabilities
356.00
+36.92%
260.00
-2.26%
266.00
-6.99%
286.00
Non Current Deferred Revenue
356.00
+36.92%
260.00
-2.26%
266.00
-6.99%
286.00
Stockholders Equity
17,657.00
+7.83%
16,375.00
+0.69%
16,262.00
+6.21%
15,311.00
Common Stock Equity
17,657.00
+7.83%
16,375.00
+0.69%
16,262.00
+6.21%
15,311.00
Capital Stock
33.00
+0.00%
33.00
+0.00%
33.00
+0.00%
33.00
Common Stock
33.00
+0.00%
33.00
+0.00%
33.00
+0.00%
33.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
198.72
+0.00%
198.72
+0.01%
198.69
+0.01%
198.67
Ordinary Shares Number
120.59
-0.04%
120.64
-1.29%
122.22
-2.20%
124.97
Treasury Shares Number
78.13
+0.07%
78.08
+2.11%
76.47
+3.76%
73.69
Additional Paid In Capital
3,600.00
+3.96%
3,463.00
+3.50%
3,346.00
+3.08%
3,246.00
Retained Earnings
29,075.00
+2.68%
28,317.00
+2.82%
27,540.00
+8.03%
25,492.00
Gains Losses Not Affecting Retained Earnings
-633.00
+40.67%
-1,067.00
-6.81%
-999.00
+23.39%
-1,304.00
Treasury Stock
14,418.00
+0.33%
14,371.00
+5.22%
13,658.00
+12.36%
12,156.00
Minority Interest
80.00
+14.29%
70.00
+25.00%
56.00
-5.08%
59.00
Other Equity Adjustments
-633.00
+40.67%
-1,067.00
-6.81%
-999.00
+23.39%
-1,304.00
Total Equity Gross Minority Interest
17,737.00
+7.86%
16,445.00
+0.78%
16,318.00
+6.17%
15,370.00
Total Capitalization
30,026.00
+9.11%
27,519.00
+3.94%
26,475.00
+13.89%
23,246.00
Invested Capital
30,026.00
+6.87%
28,096.00
+0.64%
27,918.00
+5.60%
26,437.00
Total Debt
12,369.00
+5.53%
11,721.00
+0.56%
11,656.00
+4.76%
11,126.00
Net Debt
8,169.00
-14.01%
9,500.00
+36.46%
6,962.00
+14.79%
6,065.00
Net Tangible Assets
6,843.00
+29.06%
5,302.00
+5.64%
5,019.00
+13.96%
4,404.00
Tangible Book Value
6,843.00
+29.06%
5,302.00
+5.64%
5,019.00
+13.96%
4,404.00
Commercial Paper
—
0.00
-100.00%
871.00
+46.39%
595.00
Current Notes Payable
0.00
-100.00%
577.00
+0.87%
572.00
-72.71%
2,096.00
Investments In Other Ventures Under Equity Method
638.00
-8.46%
697.00
-5.81%
740.00
-1.20%
749.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
921.00
-68.95%
2,966.00
-25.50%
3,981.00
-13.21%
4,587.00
Cash Flow From Continuing Operating Activities
921.00
-68.95%
2,966.00
-25.50%
3,981.00
-13.21%
4,587.00
Net Income From Continuing Operations
1,203.00
-0.91%
1,214.00
-51.13%
2,484.00
-11.35%
2,802.00
Depreciation
773.00
-14.87%
908.00
+6.82%
850.00
+13.48%
749.00
Amortization Cash Flow
51.00
-15.00%
60.00
-10.45%
67.00
-30.21%
96.00
Depreciation And Amortization
824.00
-14.88%
968.00
+5.56%
917.00
+8.52%
845.00
Amortization Of Intangibles
51.00
-15.00%
60.00
-10.45%
67.00
-30.21%
96.00
Other Non Cash Items
—
108.00
-4.42%
113.00
+61.43%
70.00
Stock Based Compensation
241.00
+16.43%
207.00
+18.29%
175.00
-18.98%
216.00
Asset Impairment Charge
156.00
-64.30%
437.00
+67.43%
261.00
+5.24%
248.00
Deferred Tax
75.00
+139.06%
-192.00
-14.97%
-167.00
-67.00%
-100.00
Deferred Income Tax
75.00
+139.06%
-192.00
-14.97%
-167.00
-67.00%
-100.00
Operating Gains Losses
219.00
+212.86%
70.00
-40.17%
117.00
+517.86%
-28.00
Gain Loss On Investment Securities
50.00
+308.33%
-24.00
-144.44%
54.00
-73.66%
205.00
Change In Working Capital
-1,797.00
-1266.88%
154.00
+90.12%
81.00
-84.83%
534.00
Change In Receivables
-570.00
+14.80%
-669.00
-98.52%
-337.00
-524.07%
-54.00
Change In Payables And Accrued Expense
-472.00
-337.19%
199.00
-78.25%
915.00
-6.15%
975.00
Change In Payable
-472.00
-337.19%
199.00
-78.25%
915.00
-6.15%
975.00
Change In Account Payable
-472.00
-337.19%
199.00
-78.25%
915.00
-6.15%
975.00
Change In Other Working Capital
96.00
+1700.00%
-6.00
+70.00%
-20.00
-162.50%
32.00
Change In Other Current Assets
-2,173.00
-316.65%
1,003.00
+176.10%
-1,318.00
-184.67%
-463.00
Change In Other Current Liabilities
1,322.00
+454.42%
-373.00
-144.35%
841.00
+1811.36%
44.00
Investing Cash Flow
2,273.00
+177.00%
-2,952.00
+15.46%
-3,492.00
-247.12%
-1,006.00
Cash Flow From Continuing Investing Activities
2,273.00
+177.00%
-2,952.00
+15.46%
-3,492.00
-247.12%
-1,006.00
Net PPE Purchase And Sale
-523.00
+7.92%
-568.00
+28.46%
-794.00
+29.11%
-1,120.00
Purchase Of PPE
-546.00
+5.04%
-575.00
+42.73%
-1,004.00
+11.70%
-1,137.00
Sale Of PPE
23.00
+228.57%
7.00
-96.67%
210.00
+1135.29%
17.00
Capital Expenditure
-546.00
+5.04%
-575.00
+42.73%
-1,004.00
+11.70%
-1,137.00
Net Investment Purchase And Sale
2,982.00
+263.22%
-1,827.00
+25.88%
-2,465.00
-9.56%
-2,250.00
Purchase Of Investment
-6,440.00
+21.32%
-8,185.00
-8.38%
-7,552.00
-24.85%
-6,049.00
Sale Of Investment
9,422.00
+48.19%
6,358.00
+24.99%
5,087.00
+33.90%
3,799.00
Net Business Purchase And Sale
34.00
+138.20%
-89.00
+61.80%
-233.00
-109.86%
2,364.00
Purchase Of Business
-81.00
+8.99%
-89.00
+61.80%
-233.00
+30.86%
-337.00
Gain Loss On Sale Of Business
67.00
0.00
0.00
+100.00%
-237.00
Net Other Investing Changes
-220.00
+52.99%
-468.00
—
—
Financing Cash Flow
-1,215.00
+51.15%
-2,487.00
-190.54%
-856.00
+55.28%
-1,914.00
Cash Flow From Continuing Financing Activities
-1,215.00
+51.15%
-2,487.00
-190.54%
-856.00
+55.28%
-1,914.00
Net Issuance Payments Of Debt
431.00
+60.82%
268.00
-43.93%
478.00
+134.29%
-1,394.00
Issuance Of Debt
1,481.00
-35.10%
2,282.00
-21.58%
2,910.00
+46.82%
1,982.00
Repayment Of Debt
-1,050.00
+47.86%
-2,014.00
+17.19%
-2,432.00
+27.96%
-3,376.00
Long Term Debt Issuance
1,481.00
-33.65%
2,232.00
-12.26%
2,544.00
+28.36%
1,982.00
Long Term Debt Payments
-948.00
+14.36%
-1,107.00
+52.53%
-2,332.00
+22.27%
-3,000.00
Net Long Term Debt Issuance
533.00
-52.62%
1,125.00
+430.66%
212.00
+120.83%
-1,018.00
Short Term Debt Issuance
0.00
-100.00%
50.00
-86.34%
366.00
0.00
Short Term Debt Payments
-102.00
+88.75%
-907.00
-807.00%
-100.00
+73.40%
-376.00
Net Short Term Debt Issuance
-102.00
+88.10%
-857.00
-422.18%
266.00
+170.74%
-376.00
Net Common Stock Issuance
-151.00
+81.52%
-817.00
+48.06%
-1,573.00
+24.95%
-2,096.00
Common Stock Payments
-151.00
+81.52%
-817.00
+48.06%
-1,573.00
+24.95%
-2,096.00
Common Stock Dividend Paid
-430.00
+0.23%
-431.00
+0.00%
-431.00
-9.95%
-392.00
Cash Dividends Paid
-430.00
+0.23%
-431.00
+0.00%
-431.00
-9.95%
-392.00
Repurchase Of Capital Stock
-151.00
+81.52%
-817.00
+48.06%
-1,573.00
+24.95%
-2,096.00
Proceeds From Stock Option Exercised
—
—
—
—
Net Other Financing Charges
-1,285.00
+33.25%
-1,925.00
-387.31%
670.00
-65.96%
1,968.00
Changes In Cash
1,979.00
+180.02%
-2,473.00
-573.84%
-367.00
-122.02%
1,667.00
Beginning Cash Position
2,221.00
-52.68%
4,694.00
-7.25%
5,061.00
+49.12%
3,394.00
End Cash Position
4,200.00
+89.10%
2,221.00
-52.68%
4,694.00
-7.25%
5,061.00
Free Cash Flow
375.00
-84.32%
2,391.00
-19.68%
2,977.00
-13.71%
3,450.00
Interest Paid Supplemental Data
628.00
+7.53%
584.00
+48.22%
394.00
+11.30%
354.00
Income Tax Paid Supplemental Data
231.00
-54.35%
506.00
-43.96%
903.00
+19.13%
758.00
Earnings Losses From Equity Investments
102.00
+8.51%
94.00
+49.21%
63.00
+1475.00%
4.00
Sale Of Business
115.00
0.00
0.00
-100.00%
2,701.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category